| |
| |
|
| Insider
Information: |
Fletcher Mark |
| Relationship: |
President & CEO, Direc... |
| City: |
Toronto |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
15,821,836 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,821,836 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Generex Biotechnology Corp |
GNBT |
President & CEO, Direc... |
2016-02-16 |
15,821,836 |
2007-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNBT |
Generex Biotechnology Cor... |
President & CEO |
• • – |
2016-02-16 |
4 |
OE |
$0.00 |
$4,447 |
D/D |
4,447,111 |
15,821,836 |
0 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
President & CEO |
• • – |
2016-02-09 |
4 |
OE |
$0.00 |
$14,890 |
D/D |
14,890,033 |
10,442,992 |
0 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
President & CEO |
• • – |
2014-10-06 |
4 |
OE |
$0.00 |
$471 |
D/D |
470,726 |
470,726 |
0 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
See Remarks |
• – – |
2011-04-06 |
4 |
B |
$0.24 |
$4,780 |
D/D |
20,000 |
286,077 |
2.66 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
EVP & General Counsel |
• – – |
2010-01-04 |
4 |
B |
$0.52 |
$4,524 |
D/D |
8,700 |
266,077 |
2.66 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
EVP & General Counsel |
• – – |
2009-11-13 |
4 |
B |
$0.49 |
$4,900 |
D/D |
10,000 |
257,377 |
2.66 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
EVP & General Counsel |
• – – |
2009-01-12 |
4 |
B |
$0.32 |
$3,977 |
D/D |
12,359 |
247,377 |
2.66 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
EVP & General Counsel |
• – – |
2008-10-31 |
4 |
B |
$0.37 |
$9,495 |
D/D |
25,000 |
235,018 |
2.74 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
VP & General Counsel |
• – – |
2008-04-18 |
4 |
S |
$1.14 |
$262,877 |
D/D |
(228,342) |
210,018 |
0 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
VP & General Counsel |
• – – |
2008-04-18 |
4 |
OE |
$0.89 |
$222,500 |
D/D |
250,000 |
438,360 |
0 |
- |
|
| GNBT |
Generex Biotechnology Cor... |
Exec. VP & General Counsel |
• – – |
2007-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
188,360 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
